Ceybit (CYBT)

Sri Lanka’s Own Cryptocurrency Exchange

Review Score
2.68/5
ICO Price
N/A
Pre ICO Price
N/A
Soft Cap
10,000,000 USD
Hard Cap
25,000,000 USD
Start Date
12 June 2018
End Date
31 December 2018

What is Ceybit?

 

Our platforms are essential tools needed to help our initial target users acquire, adopt and understand cryptocurrencies and other blockchain technologies.

Each of these solutions are designed to address key unique areas. The exchange addresses trading and investing. The mobile wallet address peer-to-peer payments. The gateway addresses e-commerce adoption. Together they aim to maintain Ceybit’s position as the leading provider of cryptocurrency solutions to the general public.

Ceybit software aims be Sri Lanka’s first cryptocurrency solutions provider. Our vision is to equip anyone who has access to a smartphone, tablet or a desktop computer with the tools to buy and sell cryptocurrencies securely and easily.

Ceybit’s platforms are not restricted only to Sri Lankans, our Vision is to be a global providers whose services will be accessible to everyone.

Our Mission will begin from Sri Lanka, However, Ceybit Software will initially focus on introducing the masses in Sri Lanka to the blockchain and cryptocurrency. Once the market is saturated we aim to expand and market globally.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.